Advertisement

Interchangeability of Activated Clotting Time Values Across Different Point-of-Care Systems

Published:February 17, 2012DOI:https://doi.org/10.1016/j.amjcard.2011.12.033
      Significant variability in activated clotting time (ACT) measurement exists based on the type of point-of-care system used. We sought to determine the degree of agreement in ACT measurements by the Hemochron Response and the Hemochron Signature Elite Whole Blood coagulation systems and whether these 2 systems can be used interchangeably. We prospectively compared 126-paired samples in 77 patients undergoing percutaneous coronary intervention. ACT was measured for each sample using the Hemochron Response system with glass test tubes and the Hemochron Signature Elite system with low-range ACT cuvettes simultaneously. We used correlation and Bland–Altman analyses. Mean age of the study cohort was 67 ± 11 years, 49% were women, and 65% of measurements were made after systemic anticoagulation. There was a significant correlation between the Hemochron Response and Hemochron Signature Elite systems (r = 0.84, p <0.01). However, the mean bias for the ACT measurement was 9 seconds (95% confidence interval −69 to 86). In the therapeutic range of ACT measurements, the mean bias was 15 seconds (95% confidence interval −60 to 91). Thirty-three percent of total samples had >10% disagreement and 8% of samples had >20% disagreement in the ACTs measured with the Hemochron Response compared to the Hemochron Signature Elite. In conclusion, the Hemochron Response and Hemochron Signature Elite ACT values cannot be used interchangeably. Institutions using these 2 devices should be cognizant of this difference for ensuring patient safety.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Avendaño A.
        • Ferguson J.J.
        Comparison of Hemochron and HemoTec activated coagulation time target values during percutaneous transluminal coronary angioplasty.
        J Am Coll Cardiol. 1994; 23: 907-910
        • Bland J.M.
        • Altman D.G.
        Statistical methods for assessing agreement between two methods of clinical measurement.
        Lancet. 1986; 1: 307-310
        • Ferguson J.J.
        • Dougherty K.G.
        • Gaos C.M.
        • Bush H.S.
        • Marsh K.C.
        • Leachman D.R.
        Relation between procedural activated coagulation time and outcome after percutaneous transluminal coronary angioplasty.
        J Am Coll Cardiol. 1994; 23: 1061-1065
        • Narins C.R.
        • Hillegass Jr, W.B.
        • Nelson C.L.
        • Tcheng J.E.
        • Harrington R.A.
        • Phillips H.R.
        • Stack R.S.
        • Califf R.M.
        Relation between activated clotting time during angioplasty and abrupt closure.
        Circulation. 1996; 93: 667-671
        • Chew D.P.
        • Bhatt D.L.
        • Lincoff A.M.
        • Moliterno D.J.
        • Brener S.J.
        • Wolski K.E.
        • Topol E.J.
        Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials.
        Circulation. 2001; 103: 961-966
        • King III, S.B.
        • Smith Jr, S.C.
        • Hirshfeld Jr, J.W.
        • Jacobs A.K.
        • Morrison D.A.
        • Williams D.O.
        • Feldman T.E.
        • Kern M.J.
        • O'Neill W.W.
        • Schaff H.V.
        • Whitlow P.L.
        • Adams C.D.
        • Anderson J.L.
        • Buller C.E.
        • Creager M.A.
        • Ettinger S.M.
        • Halperin J.L.
        • Hunt S.A.
        • Krumholz H.M.
        • Kushner F.G.
        • Lytle B.W.
        • Nishimura R.
        • Page R.L.
        • Riegel B.
        • Tarkington L.G.
        • Yancy C.W.
        2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
        J Am Coll Cardiol. 2008; 51: 172-209